DiaMedica Therapeutics
DMAC
DMAC
36 hedge funds and large institutions have $11M invested in DiaMedica Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.76% less ownership
Funds ownership: 12.96% → 11.2% (-1.8%)
27% less capital invested
Capital invested by funds: $15.1M → $11M (-$4.11M)
Holders
36
Holding in Top 10
1
Calls
$73K
Puts
$8K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$374K | |
| 3 | +$274K | |
| 4 |
Morgan Stanley
New York
|
+$94.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$87.5K |
Top Sellers
| 1 | -$185K | |
| 2 | -$149K | |
| 3 | -$77.4K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$73.1K |
| 5 |
First Manhattan
New York
|
-$25.8K |